The Coalition for Epidemic Preparedness Innovations (CEPI) is pleased to announce new board members Dr Soumya Swaminathan (Independent), Dr Yasuhiro Suzuki (Investor representative), and Dr Michael Ryan (Non-voting representative).
Dr Swaminathan previously served as Chief Scientist at the WHO and was instrumental in the establishment and implementation of COVAX, which has enabled access to over 1.9 billion COVID-19 vaccines globally. Prior to that Dr Swaminathan was Secretary to the Government of India for Health Research and Director General of the Indian Council of Medical Research from 2015 to 2017. She is a globally recognized researcher on tuberculosis and HIV and brings over 30 years’ experience in clinical care and research. She has also worked throughout her career to translate research into impactful programmes.
Dr Yasuhiro Suzuki has been appointed to the Board where he will sit as a representative of the CEPI Investors Council. This appointment was made following an election by CEPI’s investors’ representatives. He will replace Dr Ichiro Kurane whose term as Investor Board member has concluded. Dr Suzuki served as Vice-Minister for Health and Chief Medical and Global Health Officer for the Government of Japan’s Ministry of Health, Labour and Welfare. He served as Executive Director for Social Change & Mental Health and Executive Director of Health Technology and Pharmaceuticals at the WHO. His expertise covers infectious diseases, mental health, environmental health, and health research policy.
Dr Ryan serves as Executive Director, WHO Health Emergencies Programme. He leads WHO’s Emergency preparedness, readiness, response and research in epidemics, pandemics, humanitarian crises and other public health emergencies. He has worked at the forefront of managing acute risks to global health for more than 25 years. Dr Ryan is the strategic lead for the Research & Development Blueprint for Epidemics at WHO and was a founding member of the Global Outbreak Alert and Response Network (GOARN), which has aided the response to hundreds of disease outbreaks around the world.
Finally, Dr Peggy Hamburg’s term as Chair of CEPI’s Joint Coordination Group (JCG) has concluded and Dr Gagandeep Kang, who is a voting Board Member serving on its Executive and Investment and Equitable Access committees, will assume the post of JCG chair. Dr Kang will rotate off the CEPI Board in May 2023, but will continue as JCG Chair. Dr Nísia Trindade has also stepped down as a Board member to assume her role as Brazil’s Minister of Health.
Jane Halton, Chair of CEPI, said: “CEPI has been able to achieve a tangible difference in the world since it was first launched in 2017. It is no exaggeration to say that the contributions made by Dr Peggy Hamburg, Dr Ichiro Kurane, and Dr Nísia Trindade have strengthened CEPI’s ability to better prepare the world for the next pandemic threat. I would like to thank each of them for their stewardship and wisdom over the years. I’d also like to welcome Dr Yasuhiro Suzuki, Dr Soumya Swaminathan, and Dr Michael Ryan to the Board. Their invaluable knowledge will enrich the diversity of expert opinions and experiences on our world-class Board of Directors.”
An overview of our Board, Scientific Advisory Committee, and Joint Coordination Group and their members can be viewed on our About Us – Who We Are page.